Por favor, use este identificador para citar o enlazar este ítem:
http://dspace.udla.edu.ec/handle/33000/10332Registro completo de metadatos
| Campo DC | Valor | Lengua/Idioma |
|---|---|---|
| dc.contributor.advisor | Gia Bustamante, Jaime Francisco | - |
| dc.creator | González Salvado, Ana Carolina | - |
| dc.date.accessioned | 2018-11-23T23:25:59Z | - |
| dc.date.available | 2018-11-23T23:25:59Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | González Salvado, A. C. (2018). La asociación de hiperhomocisteinemia y los resultados pronósticos en pacientes con enfermedad cerebrovascular isquémica (Tesis de pregrado). Universidad de las Américas, Quito. | es_ES |
| dc.identifier.other | UDLA-EC-TMC-2018-14 | - |
| dc.identifier.uri | http://dspace.udla.edu.ec/handle/33000/10332 | - |
| dc.description | Background: There is evidence suggesting that hyperhomocysteinemia (plasma homocysteine levels greater than 13.9 μmol/L) is associated with the occurrence of ischemic strokes. However, the role that hyperhomocysteinemia plays in the prognostic outcome of stroke patients has shown to be controversial. The objective of this study was to determine whether hyperhomocysteinemia is associated with adverse prognostic outcomes as assessed by cognitive and neurological deficits among hospitalized ischemic stroke patients in Florida. Methods: This study is a secondary analysis of data collected by the Florida Edadncy of Health Care Administration (AHCA). We looked at patients 18 years of Edad and older with an admission diagnosis of ischemic stroke (ICD-9 cides 434.01, 434.11, and 434.91) in Florida acute care hospitals between 2008 and 2012. Hyperhomocysteinemia was defined based on report of the ICD-9 code 270.4. Logistic logistic regression was used to assess the odds of detrimental prognostic outcomes according to hypercysteinemia status. Eventos Adversoss included the following conditions: cognitive deficits, speech and languEdad deficits, aphasia, dysphasia, hemiplegia/hemiparesis, monoplegia/monoparesis, other paralytic syndromes, quadriplegia/quadriparesis, apraxia, facial weakness or droop, ataxia, vertigo and death, which were considered present if the corresponding ICD-9 codes were recorded on the AHCA database. The following confounding variables were assessed: patients Edad, Género, race, ethnicity, obesity status, current alcohol use and smoking status, and history at admission of hypertension, ischemic heart disease, atrial fibrillation, dementia, chronic renal failure hypothyroidism, diabetes, hyperlipidemia, congestive heart failure and previous stroke significance was considered at the alpha 0.01 level. | en |
| dc.description.abstract | Antecedentes: Hay evidencia que sugiere que la hiperhomocisteinemia niveles de homocisteína en plasma mayores de 13,9 μmol/l se asocia con la ocurrencia de enfermedad cerebrovascular ECV isquémica... | es_ES |
| dc.format.extent | 56 p. | es_ES |
| dc.language.iso | spa | es_ES |
| dc.publisher | Quito: Universidad de las Américas, 2018 | es_ES |
| dc.rights | openAccess | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Ecuador | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ec/ | * |
| dc.subject | ENFERMEDAD CEREBROVASCULAR | es_ES |
| dc.subject | ENFERMEDAD METABÓLICA | es_ES |
| dc.subject | PACIENTE | es_ES |
| dc.subject | ATENCIÓN MÉDICA | es_ES |
| dc.title | La asociación de hiperhomocisteinemia y los resultados pronósticos en pacientes con enfermedad cerebrovascular isquémica | es_ES |
| dc.type | bachelorThesis | es_ES |
| Aparece en las colecciones: | Medicina | |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| UDLA-EC-TMC-2018-14.pdf | 2,59 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons
